CinCor Pharma, Inc. Shareholders' Equity
CinCor Pharma, Inc. had Shareholders' Equity of $518.94 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-11-03
- 2022-09-30: Stockholders' Equity Attributable to Parent $518.94M.
- 2022-06-30: Stockholders' Equity Attributable to Parent $295.73M.
- 2022-03-31: Stockholders' Equity Attributable to Parent $315.96M.
- 2021-12-31: Stockholders' Equity Attributable to Parent -$63.72M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2022-09-30 | $518.94M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $295.73M 10-Q · filed 2022-11-03 |
| 2022-03-31 | $315.96M 10-Q · filed 2022-11-03 |
| 2021-12-31 | -$63.72M 10-Q · filed 2022-11-03 |
| 2021-09-30 | -$44.81M 10-Q · filed 2022-11-03 |
| 2021-06-30 | -$36.35M 10-Q · filed 2022-11-03 |
| 2021-03-31 | -$31.49M 10-Q · filed 2022-11-03 |
| 2020-12-31 | -$27.26M 10-Q · filed 2022-11-03 |
| 2019-12-31 | -$4.98M 10-K · filed 2022-03-22 |